Bitte verwenden Sie diesen Link, um diese Publikation zu zitieren, oder auf sie als Internetquelle zu verweisen: https://hdl.handle.net/10419/201417 
Ersetzt durch folgende Version: 
Titel: 

Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry

Dokument gelöscht auf Wunsch der Autor:in bzw. der Herausgeber:in.

Erscheinungsjahr: 
2018
Schriftenreihe/Nr.: 
DIW Discussion Papers No. 1738
Versionsangabe: 
This Version: September 5, 2018
Verlag: 
Deutsches Institut für Wirtschaftsforschung (DIW), Berlin
Zusammenfassung: 
Common ownership - where two firms are at least partially owned by the same investor - and its impact on product market outcomes has recently drawn attention from scholars and practitioners. Previous research links common ownership with higher prices. This paper focuses on implications for market entry. In particular, we consider the entry decisions of generic pharmaceutical firms into drug markets opened up by the end of regulatory protection in the US. We provide a theoretical framework that shows that greater common ownership between the brand firm (incumbent) and a potential generic entrant reduces the likelihood that the generic enters. We find robust evidence for this prediction. The negative effect of common ownership on entry is large: a one-standard-deviation increase in common ownership decreases the probability of generic entry by 9-13%. We extend our basic framework to allow for strategic interaction between generics' entry decisions, and show that our main prediction still holds. Further, our model shows that the classical idea of entry decisions being strategic substitutes can be reversed into being strategic complements for sufficiently high levels of common ownership between the brand and potential generic entrants. We find some empirical support for this prediction.
Schlagwörter: 
Market Entry
Ownership Structure
Pharma
JEL: 
G23
K21
L11
L41
L65
Dokumentart: 
Working Paper

Datei(en):
Dokument gelöscht auf Wunsch der Autor:in bzw. der Herausgeber:in am: 15. November 2019


Publikationen in EconStor sind urheberrechtlich geschützt.